Ashiya, Manish
Trips and global pharmaceutical industry Perspectives and implications - 1st - Mumbai ICFAI University Press 2007 - v, 215 Pages | Binding - Paperback |
Book Summary of Trips And Global Pharmaceutical Industry: Perspectives And Implications The Global Pharmaceutical Industry is greatly impacted by provisions of Trade Related Intellectual Property Rights (TRIPS). This industry became the centre of controversy over the conflict of right to health and right to patents. In Brazil and South Africa, governments tried to save their populace from AIDS epidemic and were forced to violate patents over AIDS drugs. About Author : Manish Ashiya holds an MBA from Mumbai University and a CFA charter from Icfai University, Hyderabad. Presently, he is working as Consulting Editor with Icfai Business School, Ahmedabad. He has two and a half years of industry experience and one year of teaching experience. Contents : Overview SECTION I HEALTH AND PHARMACEUTICAL INDUSTRY: PERSPECTIVES SECTION II TRIPS: IMPLICATIONS FOR PUBLIC HEALTH SECTION III ISSUES AND CHALLENGES
81-314-0624-5
MANAGEMENT
ALLIED SUBJECTS (SOP)
658 / ASH
Trips and global pharmaceutical industry Perspectives and implications - 1st - Mumbai ICFAI University Press 2007 - v, 215 Pages | Binding - Paperback |
Book Summary of Trips And Global Pharmaceutical Industry: Perspectives And Implications The Global Pharmaceutical Industry is greatly impacted by provisions of Trade Related Intellectual Property Rights (TRIPS). This industry became the centre of controversy over the conflict of right to health and right to patents. In Brazil and South Africa, governments tried to save their populace from AIDS epidemic and were forced to violate patents over AIDS drugs. About Author : Manish Ashiya holds an MBA from Mumbai University and a CFA charter from Icfai University, Hyderabad. Presently, he is working as Consulting Editor with Icfai Business School, Ahmedabad. He has two and a half years of industry experience and one year of teaching experience. Contents : Overview SECTION I HEALTH AND PHARMACEUTICAL INDUSTRY: PERSPECTIVES SECTION II TRIPS: IMPLICATIONS FOR PUBLIC HEALTH SECTION III ISSUES AND CHALLENGES
81-314-0624-5
MANAGEMENT
ALLIED SUBJECTS (SOP)
658 / ASH